Advertisement

Colon and Rectum Carcinoma Surveillance Counterpoint: Australia

  • Toufic El-Khoury
  • Michael Solomon
  • Jane Young
Chapter
Part of the Current Clinical Oncology book series (CCO)

Abstract

Surveillance for colorectal cancer should aim to identify recurrence at a point when therapy, in the form of surgery and/or adjuvant therapy, could impact survival duration and/or quality of life (QOL). The identification of metachronous neoplasms and early diagnosis of other conditions also improves overall survival duration [1]. Standardized surveillance strategies are also important to provide information to drive quality improvement through audit of outcomes against professional and national standards.

Keywords

Australia Postoperative Recurrence Surveillance Therapy 

References

  1. 1.
    Tjandra J, Chan M. Follow-up after curative resection of colorectal cancer: a meta-analysis. Dis Colon Rectum. 2007;50:1783–99.PubMedCrossRefGoogle Scholar
  2. 2.
    National Health and Medical Research Council (NHMRC). Clinical practice guidelines for the Prevention, early detection and management of colorectal cancer. The Cancer Council Australia, Australian Cancer Network, The Commonwealth of Australia, Canberra 2005.Google Scholar
  3. 3.
    Yun H, Lee L, Park J, et al. Local recurrence after curative resection in patients with colon and rectal cancers. Int J Colorectal Dis. 2008;23:1081–7.PubMedCrossRefGoogle Scholar
  4. 4.
    Worthington T, Wilson T, Padbury R. Case for postoperative surveillance following colorectal cancer resection. ANZ J Surg. 2004;74:43–5.PubMedCrossRefGoogle Scholar
  5. 5.
    Anthony T, Simmang C, Hyman N, et al. Practice parameters for the surveillance and follow-up of patients with colon and rectal cancer. Dis Colon Rectum. 2004;47:807–17.PubMedCrossRefGoogle Scholar
  6. 6.
    Raptis DA, Gore DM, Boulos PB. The value of CEA and CT in early diagnosis of colorectal cancer recurrence. American Society of Colon and Rectal Surgeons Tripartite Meeting 2008. Oral presentation. Boston 2008.Google Scholar
  7. 7.
    Bruinvells D, Stiggerbart A, Kievet J, Van de Velde J. Follow-up of patients with colorectal cancer: a meta-analysis. Ann Surg. 1994;219:174–82.CrossRefGoogle Scholar
  8. 8.
    Rosen M, Chan L, Beart R, Valksoin P, Anthone G. Follow-up of colorectal cancer: a meta analysis. Dis Colon Rectum. 1998;41:1116–25.PubMedCrossRefGoogle Scholar
  9. 9.
    Renehan A, Egger M, O’Dwyer S. Impact on survival of intensive follow-up after curative resection for colorectal cancer: systemic review and meta-analysis of randomised trials. Br Med J. 2002;324:813–30.CrossRefGoogle Scholar
  10. 10.
    Wattchow DA, Weller DP, Esterman A, Pilotto LS, McGorm K, Hammett Z, Platell C, Silagy C. General practice vs. surgical-based follow-up for patients with colon cancer: randomised controlled trial. Br J Cancer. 2006;94:116–21.CrossRefGoogle Scholar
  11. 11.
    Ohlesson B, Breland U, Ekberg H, Graffner H, Tranberg KG. Follow-up after curative surgery for colorectal carcinoma. Dis Colon Rectum. 1995;38:619–26.CrossRefGoogle Scholar
  12. 12.
    Makela J, Laitnen S, Kairaluoma M. Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomised trial. Arch Surg. 1995;130:1062–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Schoemaker D, Black R, Giles L, Toouli J. Yearly colonoscopy, liver CT and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology. 1998;114:7–14.PubMedCrossRefGoogle Scholar
  14. 14.
    Rodriguez-Moranta F, Salo J, Arcusa A. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective multicenter, randomised, controlled trial. J Clin Oncol. 2006;24:386–93.PubMedCrossRefGoogle Scholar
  15. 15.
    Peeters K, Marijnen C, Nagtegaal I, et al. The TME trial after a median follow up of 6 years. Ann Surg. 2007;246:693–701.PubMedCrossRefGoogle Scholar
  16. 16.
    Borie F, Daures JP, Millat B, Tretarre B. Cost and effectiveness of follow-up examinations in patients with colorectal cancer resected for cure in a French population-based study. J Gastrointest Surg. 2004;8:552–8.PubMedCrossRefGoogle Scholar
  17. 17.
    Hara M, Kanemitsu Y, Hirai T, Komori K, Kato T. Negative Serum CEA has insufficient accuracy for excluding recurrence from patients with Dukes C colorectal cancer: analysis with likelihood ratio and post test probability in a follow-up study. Dis Colon Rectum. 2008;51:1675–80.PubMedCrossRefGoogle Scholar
  18. 18.
    Howell J, Wotherspoon H, Leen E, coke T, McArdle C. Evaluation of a follow-up program after curative resection fro colorectal cancer. Br J Cancer. 1999;79:308–10.PubMedCrossRefGoogle Scholar
  19. 19.
    Scott A, Gunawardana D, Kelley B, Stuckey J, Byrne A, Ramshaw J, Fulham M. PET Changes Management and Improves Prognostic Stratification in Patients with Recurrent Colorectal Cancer: Results of a Multicenter Prospective Study. J Nucl Med. 2008;49:1451–7.PubMedCrossRefGoogle Scholar
  20. 20.
    Zakaria S, Donohue JH, Florenia G, Farnell MB, et al. Hepatic resection for colorectal metastases, value for risk scoring systems? Ann Surg. 2007;246:183–91.PubMedCrossRefGoogle Scholar
  21. 21.
    Hideyuki I, Shimada H, Ohki S, Togo S, Yamaguchi S, Ichikawa Y. Results of aggressive resection of lung metastases from colorectal carcinoma detected by intensive follow-up. Dis Colon Rectum. 2002;45:468–75.CrossRefGoogle Scholar
  22. 22.
    Heriot A, Byrne C, Lee P, Dobbs B, Tilney H, Solomon M, Mackay J, Frizelle F. Extended radical resection: the choice for locally recurrent rectal cancer. Dis Colon Rectum. 2008;51:284–91.PubMedCrossRefGoogle Scholar
  23. 23.
    Grossman EM, Johnson FE, Vigro KS, Longo WE, Fossati R. Follow-up of colorectal cancer patients after resection with curative intent: the GILDA trial. Surg Oncol. 2004;13:119–24.CrossRefGoogle Scholar
  24. 24.
    Primrose J, Mant D. A randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patient who have undergone resection for colorectal cancer with curative intent. A protocol. Website -http://www.controlled-trials.com/isrctn/pf/61091474.
  25. 25.
    Yang I, Eschrich S, Bloom G, Quackenbush J, Yeatman T. Molecular profiling predicts colon cancer survival better than Dukes staging. Ann Surg Oncol. 2004;1 Suppl 2:S54.CrossRefGoogle Scholar

Copyright information

© Humana Press 2013

Authors and Affiliations

  • Toufic El-Khoury
    • 1
  • Michael Solomon
    • 1
  • Jane Young
    • 1
  1. 1.Surgical Outcome Research Centre (SOuRCe), Royal Prince Alfred Hospital Sydney and University of SydneyCamperdownAustralia

Personalised recommendations